Versant Venture Capital Vi, L.p.

Affiliations

  • Insider at Lenz Therapeutics Inc. (LENZ), 2025-10-02
  • Insider at Lava Therapeutics Nv (LVTX), 2025-09-23
  • Insider at Monte Rosa Therapeutics Inc. (GLUE), 2024-10-30
  • Insider at Black Diamond Therapeutics Inc. (BDTX), 2024-08-30
  • Insider at Tempest Therapeutics Inc. (TPST), 2024-08-13
  • Large Shareholder at Contineum Therapeutics Inc. (CTNM), 2024-04-11
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
  • Large Shareholder at Century Therapeutics Inc. (IPSC), 2022-08-11
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2022-06-07
  • Large Shareholder at Aligos Therapeutics Inc. (ALGS), 2020-10-20
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
  • Large Shareholder at Akero Therapeutics Inc. (AKRO), 2020-07-11
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GLUE $19.00 157,895 $3,000,005.00 2,097,938 2021-06-28 Filing
IPSC $20.00 100,000 $2,000,000.00 714,095 2021-06-22 Filing
ALGS $15.00 200,000 $3,000,000.00 862,444 2020-10-20 Filing
PASG $18.00 225,000 $4,050,000.00 933,352 2020-03-03 Filing
BDTX $19.00 396,081 $7,525,539.00 1,206,603 2020-02-03 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LENZ $47.01 123 $5,782.64 764,127 2025-09-30 Filing
LENZ $47.01 177 $8,321.35 1,050,599 2025-09-30 Filing
LENZ $46.41 57,502 $2,668,483.81 764,250 2025-09-30 Filing
LENZ $46.41 83,066 $3,854,827.25 1,050,776 2025-09-30 Filing
LENZ $45.35 34,405 $1,560,428.45 821,752 2025-09-30 Filing